Pfizer Loses Drawn-Out Battle Over Generic Neurontin

Law360, New York (August 24, 2005, 12:00 AM EDT) -- A federal judge in New Jersey has ruled in favor of five generic makers in their battle against drug giant Pfizer, Inc. over rights to the epilepsy drug Neurontin.

A judge in the U.S. District Court for the District of New Jersey granted a joint motion for summary judgment filed by the defendants, Alpharma, Teva, Ivax, Apotex, and Eon, in the patent litigation regarding gabapentin, the generic version of Neurontin.

The court ruled that the defendants are entitled to summary judgment of non-infringement based on Pfizer's...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.